Skip to content

Clinical trials

Phase 3 Hypertension trials in Bulgaria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension Phase: Phase 3 Country / region: Bulgaria Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20082
20091
20112
20151
20182
20193
20201
20211
20233
20242
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Recruiting3
Active, not recruiting2
Enrolling by invitation1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca4
Boehringer Ingelheim4
Takeda3
Corcept Therapeutics2
Mineralys Therapeutics Inc.2
United Therapeutics2
Alnylam Pharmaceuticals1
Arbor Pharmaceuticals, Inc.1
CSL Behring1
KBP Biosciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension22
Cardiovascular Diseases6
Renal Insufficiency, Chronic4
Diabetes Mellitus, Type 23
Essential Hypertension3
Vascular Diseases3
ACTH Syndrome, Ectopic2
Connective Tissue Diseases2
Cushing Syndrome2
Familial Primary Pulmonary Hypertension2

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.